AxoGen (NASDAQ:AXGN) Upgraded to "Buy" by StockNews.com : co

StockNews.com upgraded shares of AxoGen (NASDAQ:AXGN – Free Report) from a hold rating to a buy rating in a report issued on Friday morning. Several other equities analysts have also recently issued reports on the stock. SVB Leerink initiated coverage on shares of AxoGen in a research note on Monday, October 16th. They issued an […]

Related Keywords

Peterj Mariani , , Jpmorgan Chase Co , Cantor Fitzgerald , Axogen Inc , Securities Exchange Commission , Canaccord Genuity Group , Principal Financial Group Inc , Envestnet Asset Management Inc , Empire Financial Management Company , Free Report , Exchange Commission , Asset Management , Financial Group , Financial Management Company , Get Free Report , Avance Nerve Graft , Axoguard Nerve Connector , Axoguard Nerve Protector , Axogen Daily , Axogen , Nasdaq Axgn , Axgn , Medical , Upgrade , Stocknews Com ,